Insider Buying: Opko Health Inc. (OPK) CEO Purchases 250,000 Shares of Stock

Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost acquired 250,000 shares of the company’s stock in a transaction dated Thursday, March 14th. The shares were purchased at an average price of $2.45 per share, for a total transaction of $612,500.00. Following the purchase, the chief executive officer now directly owns 3,068,951 shares of the company’s stock, valued at $7,518,929.95. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Phillip Md Et Al Frost also recently made the following trade(s):

  • On Wednesday, March 6th, Phillip Md Et Al Frost acquired 50,000 shares of Opko Health stock. The shares were purchased at an average price of $2.57 per share, for a total transaction of $128,500.00.
  • On Thursday, February 28th, Phillip Md Et Al Frost acquired 200,000 shares of Opko Health stock. The shares were purchased at an average price of $2.48 per share, for a total transaction of $496,000.00.
  • On Wednesday, January 16th, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The shares were purchased at an average price of $3.74 per share, for a total transaction of $37,400.00.
  • On Monday, January 14th, Phillip Md Et Al Frost acquired 15,000 shares of Opko Health stock. The shares were purchased at an average price of $3.74 per share, for a total transaction of $56,100.00.
  • On Friday, January 11th, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The shares were purchased at an average price of $3.83 per share, for a total transaction of $38,300.00.
  • On Wednesday, January 9th, Phillip Md Et Al Frost acquired 10,000 shares of Opko Health stock. The shares were purchased at an average price of $3.65 per share, for a total transaction of $36,500.00.
  • On Monday, January 7th, Phillip Md Et Al Frost acquired 55,000 shares of Opko Health stock. The shares were purchased at an average price of $3.56 per share, for a total transaction of $195,800.00.
  • On Friday, January 4th, Phillip Md Et Al Frost acquired 30,000 shares of Opko Health stock. The shares were purchased at an average price of $3.43 per share, for a total transaction of $102,900.00.
  • On Wednesday, January 2nd, Phillip Md Et Al Frost acquired 40,000 shares of Opko Health stock. The shares were purchased at an average price of $3.24 per share, for a total transaction of $129,600.00.
  • On Monday, December 31st, Phillip Md Et Al Frost acquired 135,000 shares of Opko Health stock. The shares were purchased at an average price of $2.97 per share, for a total transaction of $400,950.00.

Shares of NASDAQ:OPK traded up $0.07 during midday trading on Friday, reaching $2.49. The company had a trading volume of 100,291 shares, compared to its average volume of 5,473,214. The company has a current ratio of 1.10, a quick ratio of 0.96 and a debt-to-equity ratio of 0.03. The firm has a market cap of $1.49 billion, a PE ratio of -10.00 and a beta of 1.88. Opko Health Inc. has a one year low of $2.34 and a one year high of $6.40.

A number of analysts have recently issued reports on OPK shares. Zacks Investment Research upgraded shares of Opko Health from a “hold” rating to a “buy” rating and set a $4.00 price objective on the stock in a research note on Friday, November 30th. ValuEngine upgraded shares of Opko Health from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd. Finally, Barrington Research restated a “buy” rating and issued a $5.00 price target on shares of Opko Health in a research note on Thursday, February 28th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $9.67.

Several large investors have recently modified their holdings of OPK. Diversified Trust Co bought a new stake in shares of Opko Health in the fourth quarter worth $30,000. FDx Advisors Inc. bought a new stake in shares of Opko Health in the fourth quarter worth $33,000. Douglas Lane & Associates LLC bought a new stake in shares of Opko Health in the fourth quarter worth $42,000. Kovack Advisors Inc. bought a new stake in shares of Opko Health in the fourth quarter worth $48,000. Finally, Two Sigma Advisers LP bought a new stake in shares of Opko Health in the fourth quarter worth $49,000. Institutional investors and hedge funds own 23.73% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Insider Buying: Opko Health Inc. (OPK) CEO Purchases 250,000 Shares of Stock” was first published by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2019/03/15/insider-buying-opko-health-inc-opk-ceo-purchases-250000-shares-of-stock.html.

Opko Health Company Profile

OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases.

Further Reading: What is Depreciation?

Insider Buying and Selling by Quarter for Opko Health (NASDAQ:OPK)

Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply